Tag: DCT oversight

Scaling Oversight Approaches as DCT and Hybrid Portfolios Grow Scaling Oversight Approaches as DCT and Hybrid Portfolios Grow The shift towards decentralized clinical trials (DCT) and hybrid study designs marks a significant evolution in the clinical research landscape. As sponsors and investigators explore these innovations, the approach to monitoring and oversight must also transform. This…

Read More “Scaling Oversight Approaches as DCT and Hybrid Portfolios Grow” »

Regulatory Guidance Trends for DCT and Remote Site Oversight Introduction to Decentralized Clinical Trials (DCT) and Remote Site Oversight As the clinical research landscape evolves, decentralized clinical trials (DCT) have emerged as a prominent model, facilitating patient participation and site management from a distance. This shift is particularly important for clinical trial researchers navigating the…

Read More “Regulatory Guidance Trends for DCT and Remote Site Oversight” »

Leveraging Patient Feedback to Strengthen DCT Oversight Models Leveraging Patient Feedback to Strengthen DCT Oversight Models In the ever-evolving landscape of clinical trials, particularly with the rise of decentralized trials (DCT), effective oversight has become a cornerstone of regulatory compliance and patient safety. As the demand for innovative solutions grows, understanding how to harness patient…

Read More “Leveraging Patient Feedback to Strengthen DCT Oversight Models” »

Case Studies: DCT Oversight Models That Passed Regulatory Scrutiny Case Studies: DCT Oversight Models That Passed Regulatory Scrutiny The emergence of decentralized clinical trials (DCTs) has propelled the entire clinical research ecosystem toward innovative methodologies for data collection, patient engagement, and regulatory compliance. The oversight of DCT and hybrid sites must be structured and thorough…

Read More “Case Studies: DCT Oversight Models That Passed Regulatory Scrutiny” »

Aligning DCT Oversight With RBM, KRIs and Signal Detection Tools As the landscape of clinical trials evolves, the integration of decentralized clinical trials (DCT) presents new opportunities and challenges, particularly in terms of oversight. The application of Risk-Based Monitoring (RBM) methodologies, Key Risk Indicators (KRIs), and signal detection tools is becoming increasingly important. This tutorial…

Read More “Aligning DCT Oversight With RBM, KRIs and Signal Detection Tools” »

Managing Safety Reporting and AE Capture in Remote-First Trials Managing Safety Reporting and Adverse Event Capture in Remote-First Trials In the evolving landscape of clinical trials, the shift towards remote-first trials, also referred to as decentralized clinical trials (DCT), has necessitated a robust framework for managing safety reporting and adverse event (AE) capture. The objective…

Read More “Managing Safety Reporting and AE Capture in Remote-First Trials” »

Documentation of Oversight Responsibilities in Contracts and Quality Agreements Documentation of Oversight Responsibilities in Contracts and Quality Agreements In the dynamic landscape of clinical trials, particularly in the context of decentralized clinical trials (DCT) and hybrid sites, ensuring robust oversight through appropriate documentation is vital. This includes accurately defining oversight responsibilities in contracts and quality…

Read More “Documentation of Oversight Responsibilities in Contracts and Quality Agreements” »

Vendor and Partner Governance for Technology-Enabled DCT Sites Vendor and Partner Governance for Technology-Enabled DCT Sites The landscape of clinical trials is rapidly evolving, particularly with the rise of technology-enabled decentralized clinical trials (DCT). As clinical research organizations (CROs) and sponsors increasingly implement DCT and hybrid models, the need for robust vendor and partner governance…

Read More “Vendor and Partner Governance for Technology-Enabled DCT Sites” »

Training and Qualification of Non-Traditional Site Staff in DCT Models Training and Qualification of Non-Traditional Site Staff in DCT Models In the evolving landscape of clinical trials, decentralized clinical trial (DCT) models are increasingly becoming the norm. This shift requires thoughtful strategies for the training and qualification of non-traditional site staff. As clinical trials become…

Read More “Training and Qualification of Non-Traditional Site Staff in DCT Models” »

Oversight Strategies for Direct-to-Patient IP Shipments and Returns Oversight Strategies for Direct-to-Patient IP Shipments and Returns Clinical trials have increasingly embraced direct-to-patient (DTP) strategies, facilitated by advancements in logistics and technology. DTP clinical trials offer significant benefits, including enhanced patient engagement, expanded access to investigational products (IPs), and reduced site burden. However, they introduce unique…

Read More “Oversight Strategies for Direct-to-Patient IP Shipments and Returns” »